Prosecution Insights
Prosecution Insights
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (83%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AULAKH, CHARANJIT | 1 | 80.9% | -15.6% |
| LYLE, SOPHIA YUAN | 1 | 57.4% | +56.8% |
| DOSHER, JULIE GRACE | 1 | 33.3% | +83.3% |
| KIM, TAEYOON | 1 | 51.5% | +51.4% |
| BUNKER, AMY M | 1 | 29.2% | +46.5% |
| BOECKELMAN, JACOB A | 1 | 36.1% | +46.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18284236 | Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto | AULAKH, CHARANJIT | 1d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17919481 | Immune Cell Redirecting Compositions and Therapeutic Uses Thereof | BUNKER, AMY M | 30d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18330690 | METHODS AND SYSTEMS FOR TREATMENT OF FEEDING DISORDERS | DOSHER, JULIE GRACE | 127d overdue |
| 17908465 | Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving Enzymes | BOECKELMAN, JACOB A | 73d overdue |
| 18273973 | Methods, Devices and Systems for Generating a Chemical Gradient | LYLE, SOPHIA YUAN | 1d overdue |
| 18129399 | IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | KIM, TAEYOON | 12d |
| 17919481 | Immune Cell Redirecting Compositions and Therapeutic Uses Thereof | BUNKER, AMY M | 30d |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1796 | 1 |
| 3715 | 1 |
| 1631 | 1 |
| 1684 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18284236 | Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto | AULAKH, CHARANJIT | 1621 | §103 | Non-Final OA | 1d overdue | Pending | Sep 26, 2023 |
| 18273973 | Methods, Devices and Systems for Generating a Chemical Gradient | LYLE, SOPHIA YUAN | 1796 | §103 | Non-Final OA | 1d overdue | Pending | Jul 24, 2023 |
| 18330690 | METHODS AND SYSTEMS FOR TREATMENT OF FEEDING DISORDERS | DOSHER, JULIE GRACE | 3715 | §103 | Non-Final OA | 127d overdue | Pending | Jun 07, 2023 |
| 18129399 | IN UTERO TRANSPLANTATION OF FACTOR VIII-EXPRESSING CELLS FOR TREATMENT OF HEMOPHILIA | KIM, TAEYOON | 1631 | Other | Non-Final OA | 12d | Pending | Mar 31, 2023 |
| 17919481 | Immune Cell Redirecting Compositions and Therapeutic Uses Thereof | BUNKER, AMY M | 1684 | §103 | Final Rejection | 30d | Pending | Oct 17, 2022 |
| 17908465 | Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving Enzymes | BOECKELMAN, JACOB A | 1655 | §103 | Final Rejection | 73d overdue | Pending | Aug 31, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial